Stay updated on Dupilumab in ABPA Treatment Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in ABPA Treatment Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:24:31.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy evaluation of dupilumab on lung function in participants with Allergic Bronchopulmonary Aspergillosis (ABPA) in a clinical trial setting related to medical and healthcare publications.
    Difference
    0.1%
    Check dated 2024-06-06T14:22:28.000Z thumbnail image
  7. Check
    26 days ago
    Change Detected
    Summary
    The 'Participation Criteria 6' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' which now includes examples such as a person's general health condition or prior treatments. This change provides a clearer explanation of the eligibility criteria for clinical research participation.
    Difference
    23%
    Check dated 2024-05-22T21:03:47.000Z thumbnail image
  8. Check
    48 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:36:34.000Z thumbnail image

Stay in the know with updates to Dupilumab in ABPA Treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in ABPA Treatment Clinical Trial page.